CAR-T Therapy for the Treatment of Relapsed/Refractory CD19 Positive Large B Cell Lymphoma: Canadian Real-World Evidence

被引：1
|
作者：
Tan, Xiu Xia Sherry [1 ]
Maltez, Melissa [1 ]
Mallick, Ranjeeta [2 ]
Hamelin, Linda [1 ]
McDiarmid, Sheryl [1 ]
Kennah, Michael [1 ]
Atkins, Harold [1 ]
Kekre, Natasha K. [1 ]
机构：
[1] Ottawa Hosp, Dept Med, Ottawa, ON, Canada
[2] Ottawa Hosp, Res Inst, Ottawa, ON, Canada
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-179044
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] CD19 CAR-T cell therapy for relapsed or refractory diffuse large B cell lymphoma: Why does it fail?
    Kinoshita, Hannah
    Bollard, Catherine M.
    Toner, Keri
    SEMINARS IN HEMATOLOGY, 2023, 60 (05) : 329 - 337
  • [2] CD19 CAR-T Cell Therapy in Children with Relapsed and Refractory B-ALL
    Molostova, Olga
    Shelikhova, Larisa
    Muzalevsky, Yakov
    Kazachenok, Alexey
    Khismatullina, Rimma
    Abugova, Julia
    Kurnikova, Elena
    Trakhtman, Pavel
    Pershin, Dmitry
    Zubachenko, Viktoria
    Fadeeva, Maria
    Popov, Alexander M.
    Illarionova, Olga
    Miakova, Natalia
    Litvinov, Dmitry
    Novichkova, Galina
    Maschan, Alexey
    Maschan, Michael
    BLOOD, 2021, 138
  • [3] Real-world evidence of the safety and survival with CD19 CAR-T cell therapy for relapsed/refractory solid organ transplant-related PTLD
    McKenna, Marshall
    Epperla, Narendranath
    Ghobadi, Armin
    Liu, Jieqi
    Lazaryan, Aleksandr
    Ibrahim, Uroosa
    Jacobson, Caron A. A.
    Naik, Seema G. G.
    Nastoupil, Loretta
    Chowdhury, Sayan Mullick
    Voorhees, Timothy J. J.
    Jacobs, Miriam T.
    Farooq, Umar
    Osman, Keren
    Olszewski, Adam J. J.
    Ahmed, Sairah
    Evens, Andrew M. M.
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 202 (02) : 248 - 255
  • [4] Axicabtagene Ciloleucel CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma: Real-World Experience
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (05) : 9 - 10
  • [5] Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma
    Eugenio Galli
    Federica Sorà
    Stefan Hohaus
    Silvia Bellesi
    Francesco Autore
    Elisabetta Metafuni
    Idanna Innocenti
    John Marra
    Alberto Fresa
    Maria Assunta Limongiello
    Sabrina Giammarco
    Lucia Leccisotti
    Andrea Guarneri
    Patrizia Chiusolo
    Luca Laurenti
    Luciana Teofili
    Nicola Piccirillo
    Andrea Bacigalupo
    Simona Sica
    Bone Marrow Transplantation, 2022, 57 : 837 - 839
  • [6] CD19 CAR T-CELLS FOR RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: REAL-WORLD DATA FROM LMU MUNICH
    Bucklein, V.
    Blumenberg, V.
    Schmidt, C.
    Rejeski, K.
    Ruzicka, M.
    Mueller, N.
    Reischer, A.
    von Baumgarten, L.
    Voelkl, A.
    Wagner, B.
    Humpe, A.
    Tischer, J.
    Stemmler, H.
    von Bergwelt, M.
    Subklewe, M.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A48 - A49
  • [7] Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma
    Galli, Eugenio
    Sora, Federica
    Hohaus, Stefan
    Bellesi, Silvia
    Autore, Francesco
    Metafuni, Elisabetta
    Innocenti, Idanna
    Marra, John
    Fresa, Alberto
    Limongiello, Maria Assunta
    Giammarco, Sabrina
    Leccisotti, Lucia
    Guarneri, Andrea
    Chiusolo, Patrizia
    Laurenti, Luca
    Teofili, Luciana
    Piccirillo, Nicola
    Bacigalupo, Andrea
    Sica, Simona
    BONE MARROW TRANSPLANTATION, 2022, 57 (05) : 837 - 839
  • [8] Humanized CD19 CAR-T cells in relapsed/refractory B-ALL patients who relapsed after or failed murine CD19 CAR-T therapy
    Lihong An
    Yuehui Lin
    Biping Deng
    Zhichao Yin
    Defeng Zhao
    Zhuojun Ling
    Tong Wu
    Yongqiang Zhao
    Alex H. Chang
    Chunrong Tong
    Shuangyou Liu
    BMC Cancer, 22
  • [9] Axicabtagene Ciloleucel CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma: Real World Experience
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (02) : 13 - 15
  • [10] Decitabine-primed tandem CD19/CD22 CAR-T therapy in relapsed/refractory diffuse large B-cell lymphoma patients
    Qu, Changju
    Zou, Rui
    Wang, Peng
    Zhu, Qian
    Kang, Liqing
    Ping, Nana
    Xia, Fan
    Liu, Hailing
    Kong, Danqing
    Yu, Lei
    Wu, Depei
    Jin, Zhengming
    FRONTIERS IN IMMUNOLOGY, 2022, 13
12345